PNPLA3 and metabolic syndrome: When moving to longitudinal studies, in a cohort of 144 patients with metabolic syndrome and with a median follow‐up of 17 months, Mantovani and colleagues observed that the presence of the PNPLA3 G allele was independently associated with more rapid decline in kidney function by eGFR [103].